financetom
Business
financetom
/
Business
/
Update: Augusta Gold Releases Feasibility Study Results for its Reward Project; Initiates Strategic Review
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Augusta Gold Releases Feasibility Study Results for its Reward Project; Initiates Strategic Review
Sep 6, 2024 1:08 PM

11:58 AM EDT, 09/05/2024 (MT Newswires) -- Augusta Gold ( AUGG ) reported Thursday the results of a feasibility study for its 100% owned and "construction-ready" Reward project in Nevada, while launching a strategic review.

Among highlights, the study outlined proved and probable reserves of near 15.1 million tons grading 0.025 ounces per ton of gold for 370,000 ounces of contained gold. The project is expected to have a mine life of 7.6 years with pre-production capital cost estimated at $89.7 million.

The company said the project has all required permits in place to commence construction.

Thursday's statement noted the company's Bullfrog Project is located seven miles to the northwest and hosts Measured and Indicated Mineral Resources of 1,209,290 oz gold grading 0.53 g/t gold and Inferred Mineral Resources of 257,900 oz gold grading 0.48 g/t gold. It said "significant" synergies from the Reward Project are expected to be realized for the company's larger Bullfrog project located across the valley.

Following the release of the study, Augusta said it launched a strategic review to evaluate alternative opportunities to maximize shareholder returns, a process that can include a sale of the company. The company also agreed in principle with its lender to extend the term of its loan with the lender through to February 28, 2025.

"The Reward project is construction-ready, strategically located and anticipated to be our first development in the district and will help support the development of our larger Bullfrog project located seven miles away. The Reward Project could be in production within 12 months of commencing full-scale construction, in a rapidly growing and highly prolific district," chief executive Don Taylor said.

Augusta's shares were last seen up $0.06 to $0.74 on the Toronto Stock Exchange.

Price: 0.74, Change: +0.06, Percent Change: +8.82

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pactiv Evergreen Completes $110 Million Sale of Paper Plants to Suzano
Pactiv Evergreen Completes $110 Million Sale of Paper Plants to Suzano
Oct 2, 2024
08:49 AM EDT, 10/01/2024 (MT Newswires) -- Pactiv Evergreen ( PTVE ) said Tuesday it has completed the $110 million sale of its Pine Bluff, Ark., paper mill and Waynesville, N.C., extrusion facility to Brazilian paper producer Suzano. Pactiv President and Chief Executive Michael King said the sale will smooth the company's transition to a capital-light business model and is...
Dieselgate trial of former VW chief suspended due to ailing health
Dieselgate trial of former VW chief suspended due to ailing health
Oct 2, 2024
BERLIN, Germany (Reuters) - The criminal trial of former Volkswagen Chief Executive Martin Winterkorn over the so-called dieselgate scandal has been suspended due to his poor health, a court in Braunschweig said on Tuesday. All hearings have been cancelled because Winterkorn, who was toppled from the helm of the company in 2015 after it emerged that millions of Volkswagen cars...
Paychex Fiscal Q1 Adjusted Earnings, Revenue Rise
Paychex Fiscal Q1 Adjusted Earnings, Revenue Rise
Oct 2, 2024
08:46 AM EDT, 10/01/2024 (MT Newswires) -- Paychex ( PAYX ) reported fiscal Q1 adjusted earnings Tuesday of $1.16 per diluted share, up from $1.14 a year earlier. Analysts surveyed by Capital IQ expected $1.14. Revenue for the quarter ended Aug. 31 was $1.32 billion, compared with $1.29 billion a year earlier. Analysts polled by Capital IQ expected $1.31 billion....
BriaCell Reports 'Dramatic' Anti-tumor Response in Breast Cancer Patient in Phase 2 Study; Shares Up Pre-Bell
BriaCell Reports 'Dramatic' Anti-tumor Response in Breast Cancer Patient in Phase 2 Study; Shares Up Pre-Bell
Oct 2, 2024
08:46 AM EDT, 10/01/2024 (MT Newswires) -- BriaCell Therapeutics ( BCTX ) said Tuesday that a breast cancer patient treated in a phase 2 study of the company's Bria-IMT regimen showed a dramatic anti-tumor response. The company said treatment with its Bria-IMT regimen resulted in complete resolution of right temporal lobe brain metastasis in the patient with eye-bulging metastatic breast...
Copyright 2023-2026 - www.financetom.com All Rights Reserved